Premium
Dabrafenib plus trametinib in BRAF K601E‐mutant melanoma
Author(s) -
Rogiers A.,
Thomas D.,
Vander Borght S.,
Oord J.J.,
Bechter O.,
Dewaele M.,
Rambow F.,
Marine J.C.,
Wolter P.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.17250
Subject(s) - trametinib , dabrafenib , mutant , melanoma , cancer research , medicine , biology , metastatic melanoma , vemurafenib , phosphorylation , mapk/erk pathway , gene , genetics